ACRO BIOMEDICAL CO., LTD.
OTC · CIK 0001622996 · Fiscal year end 1231
Latest reported period: Latest published period
Revenue
$0
Operating Income
$-60,271
Net Income
$-43,774
Recent financials
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $0 | - | - |
| Operating Income | $-60,271 | - | - |
| Net Income | $-43,774 | - | - |
| Eps Diluted | 0 | - | - |
| Total Assets | $3,873 | - | - |
| Shareholders Equity | $-427,235 | - | - |
| Operating Cash Flow | $-49,821 | - | - |
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 10-Q | ACRO BIOMEDICAL CO., LTD. | 2026-05-05 | 0001640334-26-000824 |